Bloom Burton Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Bloom Burton
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Bloom Burton. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Bloom Burton.

Company	Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price
LMNL Liminal BioSciences	4/10/2023	Upgraded by	Bloom Burton	Analyst A. Borovina	Sell -> Hold		Low
OPS Opsens	3/28/2023	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
RX BioSyent	3/23/2023	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
GBNH Greenbrook TMS	2/9/2023	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		Low
DOC CloudMD Software & Services	11/16/2022	Upgraded by	Bloom Burton	Analyst P. Pandurangan	Hold -> Accumulate		N/A
MDP Medexus Pharmaceuticals	11/10/2022	Upgraded by	Bloom Burton	Analyst D. Martin	Sell -> Hold		N/A

MDP Medexus Pharmaceuticals	9/20/2022	Downgraded by	Bloom Burton	Analyst D. Martin	Hold -> Sell		N/A
DOC CloudMD Software & Services	8/24/2022	Downgraded by	Bloom Burton	Analyst P. Pandurangan	Buy -> Hold		N/A
MDNA Medicenna Therapeutics	8/16/2022	Target Lowered by	Bloom Burton		Buy	C$9.00	N/A
MDNA Medicenna Therapeutics	7/28/2022	Reiterated by	Bloom Burton		Buy	C$11.00	N/A
HLS HLS Therapeutics	7/26/2022	Reiterated by	Bloom Burton		Buy	C$22.00	N/A
MBX Microbix Biosystems	6/6/2022	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy		N/A
GBNH Greenbrook TMS	4/4/2022	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low
GUD Knight Therapeutics	3/28/2022	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	C$6.70	N/A
GUD Knight Therapeutics	3/25/2022	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
RX BioSyent	3/10/2022	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Accumulate		N/A
DOC CloudMD Software & Services	12/22/2021	Reiterated by	Bloom Burton	Analyst P. Pandurangan	Buy		N/A
ABCL AbCellera Biologics	12/19/2021	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy		Low
TMD Titan Medical	11/15/2021	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
GBNH Greenbrook TMS	10/5/2021	Reiterated by	Bloom Burton		Buy	$16.00	Medium
AUPH Aurinia Pharmaceuticals	10/1/2021	Initiated by	Bloom Burton	Analyst Prasath Pandurangan	Hold	$23.00	Medium
RPTX Repare Therapeutics	9/30/2021	Initiated by	Bloom Burton	Analyst Prasath Pandurangan	Buy	$49.00	Low
MDNA Medicenna Therapeutics	9/22/2021	Initiated by	Bloom Burton	Analyst Prasath Pandurangan	Buy	C$11.00	N/A
MDNA Medicenna Therapeutics	9/22/2021	Initiated by	Bloom Burton	Analyst Prasath Pandurangan	Buy	$11.00	Medium
BLU BELLUS Health	8/13/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
BLU BELLUS Health	8/13/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low
HLS HLS Therapeutics	8/5/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
VMD Viemed Healthcare	8/4/2021	Upgraded by	Bloom Burton	Analyst P. Pandurangan	Accumulate -> Buy		Low
VMD Viemed Healthcare	8/4/2021	Upgraded by	Bloom Burton	Analyst P. Pandurangan	Accumulate -> Buy		N/A
MDP Medexus Pharmaceuticals	8/4/2021	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A
KDNY Chinook Therapeutics	6/14/2021	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy	$40.00	Low
AUPH Aurinia Pharmaceuticals	5/7/2021	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		High
TMD Titan Medical	4/19/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
GBNH Greenbrook TMS	4/9/2021	Reiterated by	Bloom Burton		Buy	$16.00	Low
GUD Knight Therapeutics	3/26/2021	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
KDNY Chinook Therapeutics	3/22/2021	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy		High
RX BioSyent	3/18/2021	Downgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Hold		N/A
MDP Medexus Pharmaceuticals	2/23/2021	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
EPIX ESSA Pharma	2/12/2021	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
LMNL Liminal BioSciences	1/29/2021	Downgraded by	Bloom Burton	Analyst A. Borovina	Hold -> Sell		Low

CRHM CRH Medical	1/8/2021	Downgraded by	Bloom Burton	Analyst D. Martin	Hold	$3.00	N/A
CRHM CRH Medical	12/23/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A
FUSN Fusion Pharmaceuticals	12/17/2020	Reiterated by	Bloom Burton	Analyst A. Borovina	Buy		Medium
MRVFF Nuvo Pharmaceuticals	11/17/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
AUPH Aurinia Pharmaceuticals	11/3/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		Low
VMD Viemed Healthcare	10/19/2020	Reiterated by	Bloom Burton	Analyst P. Pandurangan	Accumulate		High
VMD Viemed Healthcare	10/19/2020	Reiterated by	Bloom Burton	Analyst P. Pandurangan	Accumulate		N/A
LMNL Liminal BioSciences	10/5/2020	Reiterated by	Bloom Burton	Analyst A. Borovina	Hold		Low
RPTX Repare Therapeutics	9/17/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		High
MDNA Medicenna Therapeutics	8/24/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Medium
HTL Hamilton Thorne	8/21/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
XENE Xenon Pharmaceuticals	8/13/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	$25.00	Medium
CRH CRH	8/14/2020	Reiterated by	Bloom Burton		Buy		Low
CRHM CRH Medical	8/13/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	$4.00	N/A
CRHM CRH Medical	8/12/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		High
HLS HLS Therapeutics	7/21/2020	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
GUD Knight Therapeutics	6/29/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
ZYME Zymeworks	6/14/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low
EPIX ESSA Pharma	5/24/2020	Reiterated by	Bloom Burton		Buy	$9.00	High
CPH Cipher Pharmaceuticals	5/8/2020	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Accumulate		N/A
HLS HLS Therapeutics	3/31/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
RX BioSyent	3/19/2020	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
AUPH Aurinia Pharmaceuticals	3/19/2020	Reiterated by	Bloom Burton	Analyst D. Martin	Buy	$23.00	Low
MRVFF Nuvo Pharmaceuticals	11/12/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A
GUD Knight Therapeutics	10/22/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
AUPH Aurinia Pharmaceuticals	10/2/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low
BLU BELLUS Health	9/6/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low
RX BioSyent	8/26/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
CPH Cipher Pharmaceuticals	8/12/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Hold		N/A
CRHM CRH Medical	8/1/2019	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
BLU BELLUS Health	8/1/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
MDP Medexus Pharmaceuticals	7/3/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
MRVFF Nuvo Pharmaceuticals	5/16/2019	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A
MRVFF Nuvo Pharmaceuticals	4/1/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
CPH Cipher Pharmaceuticals	3/20/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
CXRXF ADVANZ PHARMA	3/15/2019	Reiterated by	Bloom Burton	Analyst D. Martin	Hold		Low
GUD Knight Therapeutics	11/9/2018	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
BLU BELLUS Health	7/6/2018	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
MRVFF Nuvo Pharmaceuticals	3/26/2018	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
RX BioSyent	3/22/2018	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
EPI ESSA Pharma	1/18/2018	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A
EPIX ESSA Pharma	1/18/2018	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		High
MRVFF Nuvo Pharmaceuticals	11/3/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
HTL Hamilton Thorne	10/25/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
EPIX ESSA Pharma	9/12/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		Low
CPH Cipher Pharmaceuticals	8/14/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Hold		N/A
CRHM CRH Medical	7/14/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
EPIX ESSA Pharma	5/18/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		Low
MRVFF Nuvo Pharmaceuticals	5/15/2017	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A
CPH Cipher Pharmaceuticals	5/12/2017	Upgraded by	Bloom Burton	Analyst D. Martin	Hold -> Buy		N/A

MRVFF Nuvo Pharmaceuticals	5/9/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Hold		N/A
BLU BELLUS Health	3/1/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
CRHM CRH Medical	2/24/2017	Downgraded by	Bloom Burton	Analyst D. Martin	Buy -> Accumulate		N/A
RX BioSyent	2/13/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
CPH Cipher Pharmaceuticals	2/13/2017	Reiterated by	Bloom Burton	Analyst D. Martin	Hold		N/A
ABUS Arbutus Biopharma	1/9/2017	Upgraded by	Bloom Burton	Analyst D. Martin	Accumulate -> Buy		N/A
XENE Xenon Pharmaceuticals	12/22/2016	Initiated by	Bloom Burton		Buy	$14.50	N/A
ABUS Arbutus Biopharma	12/14/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
GUD Knight Therapeutics	11/10/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
AUPH Aurinia Pharmaceuticals	11/4/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
MRVFF Nuvo Pharmaceuticals	11/2/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Accumulate		N/A
CRHM CRH Medical	10/28/2016	Reiterated by	Bloom Burton	Analyst D. Martin	Buy		N/A
ACHV Achieve Life Sciences	5/3/2013	Target Raised by	Bloom Burton		Buy	$4,000.00 -> $5,000.00	N/A
ACHV Achieve Life Sciences	3/8/2013	Target Raised by	Bloom Burton			$3,600.00 -> $4,000.00	N/A
ONC Oncolytics Biotech	12/18/2012	Downgraded by	Bloom Burton		Buy -> Hold		N/A
THERF Theratechnologies	6/25/2012	Downgraded by	Bloom Burton		Hold -> Sell	$2.50 -> $0.75	N/A
ACHV Achieve Life Sciences	5/4/2012	Target Lowered by	Bloom Burton		Buy	$3,800.00 -> $3,600.00	N/A

MarketBeat Community Rating for Bloom Burton

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		20,204 (Vote Outperform)
Underperform Votes:		16,831 (Vote Underperform)
Total Votes:		37,035

MarketBeat's community ratings are surveys of what our community members think about Bloom Burton and other research firms. Vote "Outperform" if you believe Bloom Burton's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Bloom Burton's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bloom Burton Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Bloom Burton

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info